Biopharmaceutical company Incyte plans to expand its headquarters operations in Wilmington, Delaware. The project is expected to create up to 500 jobs over the coming years.
Incyte will buy two former MBNA buildings in downtown Wilmington, Bracebridge I and Bracebridge III, which will allow the biopharmaceutical company to move